{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T16:40:08Z","timestamp":1759855208263,"version":"build-2065373602"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Leibniz-Institut f\u00fcr Arbeitsforschung (IfADo)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background and aims<\/jats:title>\n            <jats:p>The generation of functionally mature hepatocytes from human induced pluripotent stem cells (iPSC) has the potential to replace primary human hepatocytes (PHH) as the gold standard in vitro model for drug screening, studies of hepatotoxicity as well as liver disease, and is considered a gateway technology to future cell therapy applications. However, we recently reported that current protocols for deriving hepatocyte-like cells (HLC) from iPSC fail to restrict differentiation to the hepatic lineage. Instead, single cell transcriptomics and protein expression analysis uncovered that current methods induce hybrid differentiation, leading to the establishment of abundant hepatic and intestinal gene expression signatures within individual HLC, thereby compromising hepatocyte functionality and phenotype.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Differentiation of iPSC to HLC was performed and followed by analysis of transcriptome changes during iPSC to HLC differentiation in comparison to PHH. Differentiation pattern clustering (DiPaC) of differentially expressed genes (DEG) and downstream bioinformatic analysis identified the gene regulatory networks (GRN) involved in establishing hybrid differentiation signatures in HLC, indicating a major influence of caudal-domain type 2 (CDX2) in HLC-IEC hybrid differentiation. CRISPR Cas9-based genetic engineering was used to generate <jats:italic>CDX2<\/jats:italic>\n              <jats:sup>\n                <jats:italic>\u2212\/\u2212<\/jats:italic>\n              <\/jats:sup> iPSC, followed by HLC differentiation, transcriptomics and intestinal and hepatic protein expression analysis. The observed phenotypic changes in <jats:italic>CDX2<\/jats:italic>\n              <jats:sup>\n                <jats:italic>\u2212\/\u2212<\/jats:italic>\n              <\/jats:sup> HLC were verified by functional analysis of bile canaliculus transport kinetics as well as intestinal enzyme activity and compared to PHH.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results and conclusion<\/jats:title>\n            <jats:p>Transcriptome analysis of WT iPSC to HLC differentiation in comparison to PHH confirmed the establishment of intestinal differentiation gene expression signatures in HLC and indicated a major role of CDX2 in erroneous lineage decision making of HLC. Absence of CDX2 during iPSC to HLC differentiation promoted hepatic specification through the induction of HHEX and PROX1, while drastically reducing intestinal differentiation signatures. <jats:italic>CDX2<\/jats:italic>\n              <jats:sup>\n                <jats:italic>\u2212\/\u2212<\/jats:italic>\n              <\/jats:sup> HLC displayed phenotypic maturation of bile canaliculi, including loss of intestine-associated membrane proteins (e.g. IBAT, SI, LCT), increase in hepatic transporters (e.g. <jats:italic>BSEP<\/jats:italic>) and size reduction, leading to closer functional and architectural resemblance to bile canaliculi formed by PHH.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Graphical abstract<\/jats:title>\n          <\/jats:sec>","DOI":"10.1186\/s13287-025-04696-6","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T16:03:48Z","timestamp":1759853028000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Elimination of CDX2 restricts intestinal hybrid differentiation signatures in stem cell-derived hepatocyte-like cells"],"prefix":"10.1186","volume":"16","author":[{"given":"Patrick","family":"Nell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonia","family":"Thomitzek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Feuerborn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Scholtz-Illigens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah M.","family":"Seidel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina","family":"Derksen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lara Maria","family":"Chilinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathrin","family":"Kattler-Lackes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nils","family":"Bl\u00fcthgen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Morkel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rn","family":"Walter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karolina","family":"Edlund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg","family":"Rahnenf\u00fchrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan G.","family":"Hengstler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,7]]},"reference":[{"key":"4696_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-020-01914-1","volume":"11","author":"X Gao","year":"2020","unstructured":"Gao X, et al. Hepatocyte-like cells derived from human induced pluripotent stem cells using small molecules: Implications of a transcriptomic study. Stem Cell Res Ther. 2020;11:1\u201321.","journal-title":"Stem Cell Res Ther"},{"key":"4696_CR2","doi-asserted-by":"publisher","DOI":"10.3791\/55355","author":"Y Wang","year":"2017","unstructured":"Wang Y, et al. Defined and scalable generation of hepatocyte-like cells from human pluripotent stem cells. J Vis Exp. 2017. https:\/\/doi.org\/10.3791\/55355.","journal-title":"J Vis Exp"},{"key":"4696_CR3","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.stemcr.2017.06.010","volume":"9","author":"Y Koui","year":"2017","unstructured":"Koui Y, et al. An in vitro human liver model by iPSC-derived parenchymal and non-parenchymal cells. Stem Cell Rep. 2017;9:490.","journal-title":"Stem Cell Rep"},{"key":"4696_CR4","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.jhep.2019.06.030","volume":"71","author":"SJ Mun","year":"2019","unstructured":"Mun SJ, et al. Generation of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids. J Hepatol. 2019;71:970\u201385.","journal-title":"J Hepatol"},{"key":"4696_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cels.2020.11.002","author":"JJ Velazquez","year":"2020","unstructured":"Velazquez JJ, et al. Gene regulatory network analysis and engineering directs development and vascularization of multilineage human liver organoids. Cell Syst. 2020. https:\/\/doi.org\/10.1016\/j.cels.2020.11.002.","journal-title":"Cell Syst"},{"key":"4696_CR6","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1053\/j.gastro.2020.10.002","volume":"160","author":"T Shinozawa","year":"2021","unstructured":"Shinozawa T, et al. High-fidelity drug-induced liver injury screen using human pluripotent stem cell-derived organoids. Gastroenterology. 2021;160:831\u201346.","journal-title":"Gastroenterology"},{"key":"4696_CR7","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.jhep.2022.07.009","volume":"77","author":"P Nell","year":"2022","unstructured":"Nell P, et al. Identification of an FXR-modulated liver-intestine hybrid state in iPSC-derived hepatocyte-like cells. J Hepatol. 2022;77:1386\u201398.","journal-title":"J Hepatol"},{"key":"4696_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s42003-022-04046-9","volume":"5","author":"AI Ardisasmita","year":"2022","unstructured":"Ardisasmita AI, et al. A comprehensive transcriptomic comparison of hepatocyte model systems improves selection of models for experimental use. Commun Biol. 2022;5:1\u201315.","journal-title":"Commun Biol"},{"key":"4696_CR9","doi-asserted-by":"publisher","unstructured":"Crawford JM, Bioulac-Sage P, Hytiroglou P. Structure, function and responses to injury. MacSween\u2019s pathology of the liver, eighth edition. 2024. p. 1\u201395. https:\/\/doi.org\/10.1016\/B978-0-7020-8228-3.00001-6.","DOI":"10.1016\/B978-0-7020-8228-3.00001-6"},{"key":"4696_CR10","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1002\/hep.28965","volume":"65","author":"PLM Jansen","year":"2017","unstructured":"Jansen PLM, et al. The ascending pathophysiology of cholestatic liver disease. Hepatology. 2017;65:722\u201338.","journal-title":"Hepatology"},{"key":"4696_CR11","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.ydbio.2007.05.028","volume":"308","author":"MP Hunter","year":"2007","unstructured":"Hunter MP, et al. The homeobox gene Hhex is essential for proper hepatoblast differentiation and bile duct morphogenesis. Dev Biol. 2007;308:355.","journal-title":"Dev Biol"},{"key":"4696_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0090791","volume":"9","author":"H Watanabe","year":"2014","unstructured":"Watanabe H, et al. HHEX promotes hepatic-lineage specification through the negative regulation of Eomesodermin. PLoS ONE. 2014;9:e90791.","journal-title":"PLoS ONE"},{"key":"4696_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2023.149182","volume":"686","author":"Q Jin","year":"2023","unstructured":"Jin Q, et al. Hhex and Prox1a synergistically dictate the hepatoblast to hepatocyte differentiation in zebrafish. Biochem Biophys Res Commun. 2023;686:149182.","journal-title":"Biochem Biophys Res Commun"},{"key":"4696_CR14","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1242\/dev.099481","volume":"141","author":"A Seth","year":"2014","unstructured":"Seth A, et al. Prox1 ablation in hepatic progenitors causes defective hepatocyte specification and increases biliary cell commitment. Development (Cambridge). 2014;141:538\u201347.","journal-title":"Development (Cambridge)"},{"key":"4696_CR15","doi-asserted-by":"publisher","DOI":"10.1242\/dev.179432","volume":"146","author":"L Chen","year":"2019","unstructured":"Chen L, et al. HNF4 factors control chromatin accessibility and are redundantly required for maturation of the fetal intestine. Development. 2019;146:dev179432.","journal-title":"Development"},{"key":"4696_CR16","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1016\/j.stemcr.2023.06.008","volume":"18","author":"EKW Lo","year":"2023","unstructured":"Lo EKW, et al. Platform-agnostic cell net enables cross-study analysis of cell fate engineering protocols. Stem Cell Rep. 2023;18:1721\u201342.","journal-title":"Stem Cell Rep"},{"key":"4696_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2021.109728","author":"T Brecklinghaus","year":"2022","unstructured":"Brecklinghaus T, et al. The hepatocyte export carrier inhibition assay improves the separation of hepatotoxic from non-hepatotoxic compounds. Chem Biol Interact. 2022. https:\/\/doi.org\/10.1016\/j.cbi.2021.109728.","journal-title":"Chem Biol Interact"},{"key":"4696_CR18","doi-asserted-by":"publisher","DOI":"10.3824\/STEMBOOK.1.25.1","author":"AM Zorn","year":"2008","unstructured":"Zorn AM. Liver development. Stembook. 2008. https:\/\/doi.org\/10.3824\/STEMBOOK.1.25.1.","journal-title":"Stembook"},{"key":"4696_CR19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/dvdy.21810","volume":"238","author":"RI Sherwood","year":"2009","unstructured":"Sherwood RI, Chen TYA, Melton DA. Transcriptional dynamics of endodermal organ formation. Dev Dyn. 2009;238:29\u201342.","journal-title":"Dev Dyn"},{"key":"4696_CR20","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ydbio.2021.12.014","volume":"483","author":"T Foley","year":"2022","unstructured":"Foley T, Lohnes D. Cdx regulates gene expression through PRC2-mediated epigenetic mechanisms. Dev Biol. 2022;483:22\u201333.","journal-title":"Dev Biol"},{"key":"4696_CR21","unstructured":"T. A. Bio Europe, Certificate of Analysis Cellartis\u00ae Human iPS Cell Line 18 (ChiPSC18). 2018."},{"key":"4696_CR22","unstructured":"Navigating ethical and regulatory requirements in human biospecimen collection and use | BioIVT Blog. https:\/\/bioivt.com\/blogs\/navigating-ethical-and-regulatory-requirements-in-human-biospecimen-collection-and-use. Accessed 26 June 2025."},{"key":"4696_CR23","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202114123","author":"F Uhlitz","year":"2021","unstructured":"Uhlitz F, et al. Mitogen-activated protein kinase activity drives cell trajectories in colorectal cancer. EMBO Mol Med. 2021. https:\/\/doi.org\/10.15252\/emmm.202114123.","journal-title":"EMBO Mol Med"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04696-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04696-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04696-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T16:03:50Z","timestamp":1759853030000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-025-04696-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,7]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4696"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04696-6","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,7]]},"assertion":[{"value":"20 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Human induced pluripotent stem cells were purchased from Cellartis, Takara Bio Europe, and were generated according to the iPSC derivation process at Takara Bio Europe AB following informed consent procedures and all applicable laws in Sweden and EU, approved by the EudraCT and the French Ethics Committee (CPP ICF XI\/ Les Comit\u00e9s de protection des personnes; CPP) []. Primary human hepatocytes were obtained from BioIVT, UK, guaranteeing informed consent procedures and ethical principles in accordance with applicable law []. Micro-dissected normal colon tissue of anonymized patients was provided by the Institute of Pathology, Charit\u00e9-Universit\u00e4tsmedizin Berlin, ensuring informed consent procedures and ethical standards under applicable law, as approved on September 3rd, 2019 by vote EA4\/164\/19 of the ethics commission of Charit\u00e9-Universit\u00e4tsmedizin Berlin with title \u2018Transcriptomic Analysis of Solid Tumors for the Determination of Therapeutic Profiles\u2019, as published previously [].","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"543"}}